Back to College of Pharmacy home

 

College of Pharmacy Social Media

Tretyakova Research Group

 

Dr. Natalia Tretyakova, Ph.D.
760E CCRB Cancer Center
Email: trety001@umn.edu
Main Lab Phone (790 CCRB) 612-624-0638
HPLC Room 1 (735C CCRB) 612-626-4879
HPLC Room 2 (735A CCRB) 612-625-6244
Natalia's Office (760E CCRB) 612-626-3432
Student Office (760G CCRB) 612-625-5132
Office Fax: 612-626-5135

Synthetic Lab (9-153 WDH) 612-624-4643
Molecular Biology Lab (Dr. Campbell's Lab in NHH) 612-625-8491

Natalia's C.V.: MS Word format or Adobe Acrobat

Related Links

Group Meetings

Research Areas

Group Members

Publications

Tretyakova group photo
 
The majority of genetic changes observed in human cancer are not inherited, but have environmental causes. These genetic alterations originate when DNA is chemically altered by chemicals present in the environment, our diet, and also produced naturally as a result of normal metabolism. We are developing novel methods to chemically identify and map the location of carcinogen-induced DNA damage within genes often found mutated in cancer, those that control cell growth and differentiation. This research will help establish a link between specific DNA damaging agents and genetic changes observed in cancer, providing important insights into the origins of cancer and offering new strategies for cancer prevention and treatment.
 
Lab News
 

April 2009
Congratulations to Uthpala! His poster "Exocyclic deoxyadenosine adducts of diepoxybutane: synthesis, structural elucidation, and mechanistic studies" was named the "Graduate & Professional Research Project of the Year" with a $500 AWARD was received from the GAPSA (Graduate and Professional Student Assembly, University of Minnesota) on April, 25 2009. Great job, Uthpala!

Best of luck to Rachel! Rachel Loeber recently graduated from our group to join the group of Prof. Deborah Ferrington, Ph.D. (U of M Department of Ophthalmology) as a postdoctoral associate. Rachel will be investigating how proteasome structure and function change with aging and disease.

Erin Michalson-Richie presented a poster "DNA-PROTEIN CROSS-LINKING BY ANTITUMOR DNA ALKYLATING DRUGS" at the 100th national meeting of the American Association for Cancer Research in Denver on April 21, 2009.


 


December 2007
Our proposal "DNA-protein cross-linking in carcinogenesis and cancer therapy" is funded by the AHC.

 


September 2007
Brock's paper "Sequence distribution of acetaldehyde-derived N 2-ethyl-dG adducts along duplex DNA" is published in CRT.  PubMed citation
news.9.2007

 


April 2007
First detection of diepoxybutane-specific DNA-DNA cross-links in vivo is reported.  PubMed citation
news.4.2007

 


March 2007
Article describing the first synthesis of DNA oligonucleotides containing monoepoxide adducts of diepoxybutane appears in Chemical Research in Toxicology.  PubMed citation
news.3.2007

 


January 2007
Novel DNA-DNA cross-link of diepoxybutane is identified.  PubMed citation
news.1.2007

 


May 2006
Rachel's paper on DNA protein cross-links is featured on the cover of Chemical Research in Toxicology.  PubMed citation
news.5.2006
news.5.2006.toc